Patents by Inventor Thomas Glonek

Thomas Glonek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200297591
    Abstract: A topical phospholipid formulation is provided that includes a phospholipid component. The phospholipid component is anionic and exhibits a net negative charge at physiologic pH. Methods of preparing such a formulation are also provided.
    Type: Application
    Filed: March 12, 2020
    Publication date: September 24, 2020
    Inventors: Thomas GLONEK, Jack GREINER, Donald KORB, Hridaya BHARGAVA
  • Publication number: 20190282465
    Abstract: A topical phospholipid formulation is provided that includes a phospholipid component. The phospholipid component is anionic and exhibits a net negative charge at physiologic pH. Methods of preparing such a formulation are also provided.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 19, 2019
    Inventors: Thomas GLONEK, Jack GREINER, Donald KORB, Hridaya BHARGAVA
  • Patent number: 7832857
    Abstract: The present invention provides a contact lens from Gluconacetobacter xylinus cellulose material.
    Type: Grant
    Filed: August 18, 2008
    Date of Patent: November 16, 2010
    Inventors: Dennis J. Levinson, Thomas Glonek
  • Publication number: 20100039612
    Abstract: The present invention provides a contact lens from Gluconacetobacter xylinus cellulose material.
    Type: Application
    Filed: August 18, 2008
    Publication date: February 18, 2010
    Inventors: Dennis J. Levinson, Thomas Glonek
  • Publication number: 20060257842
    Abstract: The cryopreservation media utilizes naturally occurring endogenous molecules and their chemical derivatives which act as osmotically active cryopreservative agents as well as molecules which insert into and protect specific regions of cellular membranes, lead to membrane repair, maintain normal cellular levels of energy metabolites, and act as antioxidants. Cryoperserved cells can be returned to a pre- cryopreservation state without damaging the cells resulting in a very high survival rate.
    Type: Application
    Filed: April 21, 2006
    Publication date: November 16, 2006
    Inventors: Jay Pettegrew, Thomas Glonek, Richard McClure, Kanagasabai Panchalingam
  • Patent number: 5851543
    Abstract: A composition and method for treatment of skin. The composition comprises a pharmaceutically acceptable carrier containing a bilayer component having one or more polar terminus groups and one or more non-polar terminus groups separated from said polar terminus groups capable of penetrating the outer surface of the skin to form an aligned bilayer within the stratum corneum. The bilayer assists in the formation of bilayer lamellae that is believed to replicate the bilayer lamellae present in healthy skin. The composition is topically applied to the skin as often as is required.
    Type: Grant
    Filed: November 26, 1997
    Date of Patent: December 22, 1998
    Assignee: Shipley Company, L.L.C.
    Inventors: Donald R. Korb, Thomas Glonek, Jack V. Greiner
  • Patent number: 5738856
    Abstract: A composition and method for treatment of skin. The composition comprises a pharmaceutically acceptable carrier containing a bilayer component having one or more polar terminus groups and one or more non-polar terminus groups separated from said polar terminus groups capable of penetrating the outer surface of the skin to form an aligned bilayer within the stratum corneum. The bilayer assists in the formation of bilayer lamellae that is believed to replicate the bilayer lamellae present in healthy skin. The composition is topically applied to the skin as often as is required.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: April 14, 1998
    Assignee: Ocular Research of Boston, Inc.
    Inventors: Donald R. Korb, Thomas Glonek, Jack V. Greiner
  • Patent number: 5578586
    Abstract: A method and composition for reducing evaporation of an aqueous layer from the surface of the eye. The method comprises applying an admixture of a charged phospholipid and a non-polar oil over the eye, preferably in the form of a meta-stable oil in water emulsion in a dosage not exceeding 100 microliters.
    Type: Grant
    Filed: February 4, 1994
    Date of Patent: November 26, 1996
    Assignee: Ocular Research of Boston, Inc.
    Inventors: Thomas Glonek, Jack V. Greiner, Donald R. Korb
  • Patent number: 5371108
    Abstract: A method and composition for reducing evaporation of an aqueous layer from the surface of the eye. The method comprises applying a gel of oil and wax over the eye, preferably in the form of a meta-stable oil in water emulsion in a dosage not exceeding 100 microliters. The gel is formed by gelling a hydrocarbon oil with a wax, preferably dispersed in aqueous medium at a pH of at least about 8.0.
    Type: Grant
    Filed: March 15, 1993
    Date of Patent: December 6, 1994
    Assignee: Ocular Research of Boston, Inc.
    Inventors: Donald R. Korb, Thomas Glonek
  • Patent number: 5294607
    Abstract: A method and composition for reducing evaporation of an aqueous layer from the surface of the eye. The method comprises applying an admixture of a charged phospholipid and a non-polar oil over the eye, preferably in the form of a meta-stable oil in water emulsion in a dosage not exceeding 100 microliters.
    Type: Grant
    Filed: June 9, 1992
    Date of Patent: March 15, 1994
    Assignee: Ocular Research of Boston, Inc.
    Inventors: Thomas Glonek, Jack V. Greiner, Donald R. Korb
  • Patent number: 5278151
    Abstract: A method and composition for reducing evaporation of an aqueous layer from the surface of the eye. The method comprises applying an admixture of a charged phospholipid and a non-polar oil over the eye, preferably in the form of a finely divided oil in water emulsion.
    Type: Grant
    Filed: June 9, 1992
    Date of Patent: January 11, 1994
    Assignee: Ocular Research of Boston, Inc.
    Inventors: Donald R. Korb, Thomas Glonek, Jack Greiner
  • Patent number: 4914088
    Abstract: A method and composition for treating dry eye. The method comprises addition of a positively or negatively charged, complex phospholipid to the ocular surface of the eye. The phospholipid is desirably added in a treatment composition, preferably in the form of an aqueous emulsion. It is believed that the phospholipid component of the treatment composition permits replication of a tear film.
    Type: Grant
    Filed: October 23, 1987
    Date of Patent: April 3, 1990
    Inventors: Thomas Glonek, Jack V. Greiner, Donald R. Korb